Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2020 Filed Dec 3, 2020 23:51 UTC |
Eisner MarkIncoming Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $41.25 | $0.00 |
DisclosureSEC source: 0001209191-20-061651 · doc4.xml · derivative · entry 2 Eisner Mark · CIK 0001834161 · Incoming Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-12-01 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vest on December 1, 2021 and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 23:51 UTC |
Eisner MarkIncoming Chief Medical Officer
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-061651 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · Incoming Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on December 1, 2021, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:52 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,082 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-20-059427 · doc4.xml · derivative · entry 2 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,082 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 21:52 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
Exercise / conversionCommon Stock | 7,082 | $14.58 | $103,220.15 |
DisclosureSEC source: 0001209191-20-059427 · doc4.xml · nonDerivative · entry 1 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 21:19 UTC |
Yu K PeonyChief Medical Officer
|
SaleCommon Stock | 3,351 | $44.01 | $147,477.51 |
DisclosureSEC source: 0001209191-20-051174 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,934 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 22:03 UTC |
Cotroneo PatSVP, Finance and CFO
|
SaleCommon Stock | 3,070 | $43.63 | $133,944.10 |
DisclosureSEC source: 0001209191-20-050998 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,226 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 23:36 UTC |
Yu K PeonyChief Medical Officer
|
Tax withholdingCommon Stock | 3,291 | $42.16 | $138,748.56 |
DisclosureSEC source: 0001209191-20-050052 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,285 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 23:32 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
Tax withholdingCommon Stock | 2,728 | $42.16 | $115,012.48 |
DisclosureSEC source: 0001209191-20-050049 · doc4.xml · nonDerivative · entry 1 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,413 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 23:30 UTC |
Cotroneo PatSVP, Finance and CFO
|
Tax withholdingCommon Stock | 3,014 | $42.16 | $127,070.24 |
DisclosureSEC source: 0001209191-20-050048 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,296 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 23:28 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 3,038 | $42.16 | $128,082.08 |
DisclosureSEC source: 0001209191-20-050046 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,615 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:33 UTC |
Yu K PeonyChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049620 · doc4.xml · derivative · entry 3 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 10,000 shares Expires 2024-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:33 UTC |
Yu K PeonyChief Medical Officer
|
SaleCommon Stock | 10,000 | $50.89 | $508,900.00 |
DisclosureSEC source: 0001209191-20-049620 · doc4.xml · nonDerivative · entry 2 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,576 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:33 UTC |
Yu K PeonyChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $18.00 | $180,000.00 |
DisclosureSEC source: 0001209191-20-049620 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,671 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · derivative · entry 7 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,579 Underlying: Common Stock · 8,671 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,696 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · derivative · entry 6 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,696 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 637 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · derivative · entry 5 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,618 Underlying: Common Stock · 637 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC |
Cotroneo PatSVP, Finance and CFO
|
SaleCommon Stock | 15,004 | $50.91 | $763,853.64 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,310 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $50.89 to $51.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionCommon Stock | 8,671 | $25.40 | $220,243.40 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionCommon Stock | 5,696 | $19.39 | $110,445.44 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 20:30 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionCommon Stock | 637 | $29.66 | $18,893.42 |
DisclosureSEC source: 0001209191-20-049618 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 21:58 UTC |
Schoeneck James ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001209191-20-047985 · doc4.xml · derivative · entry 3 Schoeneck James A · CIK 0001420987 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2022-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 21:58 UTC |
Schoeneck James ADirector
|
Exercise / conversionCommon Stock | 6,000 | $5.95 | $35,700.00 |
DisclosureSEC source: 0001209191-20-047985 · doc4.xml · nonDerivative · entry 1 Schoeneck James A · CIK 0001420987 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 11, 2020 20:34 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · derivative · entry 7 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2024-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 11, 2020 Filed Aug 11, 2020 20:34 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · derivative · entry 6 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,696 Underlying: Common Stock · 3,750 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 11, 2020 Filed Aug 11, 2020 20:34 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionCommon Stock | 3,500 | $18.00 | $63,000.00 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2020 Filed Aug 11, 2020 20:34 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionCommon Stock | 3,750 | $19.39 | $72,712.50 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 20:34 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,554 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · derivative · entry 5 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,446 Underlying: Common Stock · 22,554 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 20:34 UTC |
Cotroneo PatSVP, Finance and CFO
|
SaleCommon Stock | 22,554 | $48.00 | $1,082,592.00 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,060 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 20:34 UTC |
Cotroneo PatSVP, Finance and CFO
|
Exercise / conversionCommon Stock | 22,554 | $19.39 | $437,322.06 |
DisclosureSEC source: 0001209191-20-046134 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:50 UTC |
Cravatt BenjaminDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,400 | $0.00 Strike: $42.65 | $0.00 |
DisclosureSEC source: 0001209191-20-045770 · doc4.xml · derivative · entry 3 Cravatt Benjamin · CIK 0001819573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Common Stock · 10,400 shares Expires 2030-08-05 F3 · derivative.exercise_date: Option vests quarterly over three years from August 5, 2020. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:50 UTC |
Cravatt BenjaminDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,496 | $0.00 Strike: $42.65 | $0.00 |
DisclosureSEC source: 0001209191-20-045770 · doc4.xml · derivative · entry 2 Cravatt Benjamin · CIK 0001819573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,496 Underlying: Common Stock · 6,496 shares Expires 2030-08-05 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:50 UTC |
Cravatt BenjaminDirector
|
GrantCommon Stock | 3,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045770 · doc4.xml · nonDerivative · entry 1 Cravatt Benjamin · CIK 0001819573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,914 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:45 UTC |
Brennan AoifeDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,400 | $0.00 Strike: $42.65 | $0.00 |
DisclosureSEC source: 0001209191-20-045766 · doc4.xml · derivative · entry 3 Brennan Aoife · CIK 0001714563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Common Stock · 10,400 shares Expires 2030-08-05 F3 · derivative.exercise_date: Option vests quarterly over three years from August 5, 2020. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:45 UTC |
Brennan AoifeDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,496 | $0.00 Strike: $42.65 | $0.00 |
DisclosureSEC source: 0001209191-20-045766 · doc4.xml · derivative · entry 2 Brennan Aoife · CIK 0001714563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,496 Underlying: Common Stock · 6,496 shares Expires 2030-08-05 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:45 UTC |
Brennan AoifeDirector
|
GrantCommon Stock | 3,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045766 · doc4.xml · nonDerivative · entry 1 Brennan Aoife · CIK 0001714563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,914 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 23:33 UTC |
Yu K PeonyChief Medical Officer
|
SaleCommon Stock | 3,351 | $42.35 | $141,914.85 |
DisclosureSEC source: 0001209191-20-043888 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,576 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:51 UTC |
Wettig ThaneChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $42.08 | $0.00 |
DisclosureSEC source: 0001209191-20-038795 · doc4.xml · derivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2030-06-22 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vest on June 22, 2021 and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:51 UTC |
Wettig ThaneChief Commercial Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-038795 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,600 F1 · kind: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on June 22, 2021, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 22:35 UTC |
Cotroneo PatSVP, Finance and CFO
|
SaleCommon Stock | 3,928 | $39.68 | $155,863.04 |
DisclosureSEC source: 0001209191-20-037710 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,060 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 10:59 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
PurchaseCommon Stock | 19,800 | $35.28 | $698,599.44 |
DisclosureSEC source: 0001209191-20-036174 · doc4.xml · nonDerivative · entry 2 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 27,800 F2 · price: The shares were purchased in the open market at prices ranging from $35.22 to $35.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 10:59 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
PurchaseCommon Stock | 8,000 | $36.29 | $290,282.40 |
DisclosureSEC source: 0001209191-20-036174 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 8,000 F1 · price: The shares were purchased in the open market at prices ranging from $35.75 to $36.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 09, 2020 Filed Jun 12, 2020 01:22 UTC |
Rosenkranz Roberto PedroDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $19.05 | $0.00 |
DisclosureSEC source: 0001209191-20-036173 · doc4.xml · derivative · entry 4 Rosenkranz Roberto Pedro · CIK 0001621332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2026-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| June 09, 2020 Filed Jun 12, 2020 01:22 UTC |
Rosenkranz Roberto PedroDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $28.65 | $0.00 |
DisclosureSEC source: 0001209191-20-036173 · doc4.xml · derivative · entry 3 Rosenkranz Roberto Pedro · CIK 0001621332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2027-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| June 09, 2020 Filed Jun 12, 2020 01:22 UTC |
Rosenkranz Roberto PedroDirector
|
Exercise / conversionCommon Stock | 12,000 | $19.05 | $228,600.00 |
DisclosureSEC source: 0001209191-20-036173 · doc4.xml · nonDerivative · entry 2 Rosenkranz Roberto Pedro · CIK 0001621332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2020 Filed Jun 12, 2020 01:22 UTC |
Rosenkranz Roberto PedroDirector
|
Exercise / conversionCommon Stock | 12,000 | $28.65 | $343,800.00 |
DisclosureSEC source: 0001209191-20-036173 · doc4.xml · nonDerivative · entry 1 Rosenkranz Roberto Pedro · CIK 0001621332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:48 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 3,038 | $33.61 | $102,107.18 |
DisclosureSEC source: 0001209191-20-035698 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,653 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 678 shares acquired on May 15, 2020 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:47 UTC |
Cotroneo PatSVP, Finance and CFO
|
Tax withholdingCommon Stock | 2,156 | $33.61 | $72,463.16 |
DisclosureSEC source: 0001209191-20-035697 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,988 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 678 shares acquired on May 15, 2020 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:45 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
Tax withholdingCommon Stock | 2,728 | $33.61 | $91,688.08 |
DisclosureSEC source: 0001209191-20-035694 · doc4.xml · nonDerivative · entry 1 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,141 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 678 shares acquired on May 15, 2020 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:46 UTC |
Yu K PeonyChief Medical Officer
|
Tax withholdingCommon Stock | 3,292 | $33.61 | $110,644.12 |
DisclosureSEC source: 0001209191-20-035695 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,927 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 678 shares acquired on May 15, 2020 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:34 UTC |
Schoeneck James ADirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035158 · doc4.xml · derivative · entry 3 Schoeneck James A · CIK 0001420987 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.